93 related articles for article (PubMed ID: 21220365)
1. An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.
Gomes M; Ramacciotti E; Hoppensteadt D; Walenga JM; Lewis B; Thethi I; Fareed J
Clin Appl Thromb Hemost; 2011 Feb; 17(1):66-9. PubMed ID: 21220365
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence of generic and branded subcutaneous enoxaparin: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects.
Feng L; Shen-Tu J; Liu J; Chen J; Wu L; Huang M
Clin Ther; 2009 Jul; 31(7):1559-67. PubMed ID: 19695405
[TBL] [Abstract][Full Text] [Related]
3. Recurrent life-threatening deep tissue hematomas after switching to generic enoxaparin: a report and perspective on the approval process for biological compounds.
Kaffenberger BH; Bekaii-Saab T
Clin Appl Thromb Hemost; 2012; 18(1):104-6. PubMed ID: 21873360
[TBL] [Abstract][Full Text] [Related]
4. Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars.
Grampp G; Bonafede M; Felix T; Li E; Malecki M; Sprafka JM
Expert Opin Drug Saf; 2015 Mar; 14(3):349-60. PubMed ID: 25557261
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the biological activity of 2 formulations of enoxaparin in 12 healthy volunteers.
Sharma V; Madhu S; Natarajan P; Muniyandi G; Jaiswal V; Saxena R
Clin Appl Thromb Hemost; 2010 Aug; 16(4):387-93. PubMed ID: 19671565
[TBL] [Abstract][Full Text] [Related]
6. Structure and haemostatic effects of generic versions of enoxaparin available for clinical use in Brazil: similarity to the original drug.
Glauser BF; Vairo BC; Oliveira SN; Cinelli LP; Pereira MS; Mourão PA
Thromb Haemost; 2012 Feb; 107(2):302-14. PubMed ID: 22234635
[TBL] [Abstract][Full Text] [Related]
7. FDA approves generic enoxaparin.
Voelker R
JAMA; 2010 Aug; 304(8):844. PubMed ID: 20736461
[No Abstract] [Full Text] [Related]
8. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
Marlovits S; Striessnig G; Schuster R; Stocker R; Luxl M; Trattnig S; Vécsei V
Arthroscopy; 2007 Jul; 23(7):696-702. PubMed ID: 17637403
[TBL] [Abstract][Full Text] [Related]
9. Administering an enoxaparin injection.
Rushing J
Nursing; 2008 Mar; 38(3):19. PubMed ID: 18418159
[No Abstract] [Full Text] [Related]
10. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
Kuczka K; Harder S; Picard-Willems B; Warnke A; Donath F; Bianchini P; Parma B; Blume H
J Clin Pharmacol; 2008 Oct; 48(10):1189-96. PubMed ID: 18716314
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
[TBL] [Abstract][Full Text] [Related]
14. Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators.
J Am Coll Cardiol; 1997 Jun; 29(7):1474-82. PubMed ID: 9180107
[TBL] [Abstract][Full Text] [Related]
15. Skin necrosis induced by generic enoxaparin.
Gucalp A; Parameswaran R; Lacouture M; Abou-Alfa G; Soff G
Am J Hematol; 2013 Apr; 88(4):339. PubMed ID: 23450519
[No Abstract] [Full Text] [Related]
16. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
17. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin.
Spinal Cord Injury Thromboprophylaxis Investigators
J Trauma; 2003 Jun; 54(6):1116-24; discussion 1125-6. PubMed ID: 12813332
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
[TBL] [Abstract][Full Text] [Related]
19. Enoxaparin (Clexane) HITS.
Watters M
Anaesth Intensive Care; 1996 Oct; 24(5):616-7. PubMed ID: 9027216
[No Abstract] [Full Text] [Related]
20. Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparins.
Walenga JM; Jeske WP; Escalante V; Hoppensteadt D; Fareed J; Bakhos M
Int Angiol; 2012 Dec; 31(6):517-25. PubMed ID: 23222929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
